Patents by Inventor Eri Ooboki

Eri Ooboki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10308636
    Abstract: The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: June 4, 2019
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Kunio Saruta, Norimitsu Hayashi, Osamu Sakurai, Hiroaki Sawamoto, Eri Ooboki
  • Publication number: 20170050950
    Abstract: The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.
    Type: Application
    Filed: August 29, 2016
    Publication date: February 23, 2017
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Kunio SARUTA, Norimitsu HAYASHI, Osamu SAKURAI, Hiroaki SAWAMOTO, Eri OOBOKI
  • Patent number: 9546155
    Abstract: The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: January 17, 2017
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Kunio Saruta, Norimitsu Hayashi, Osamu Sakurai, Hiroaki Sawamoto, Eri Ooboki
  • Publication number: 20150158844
    Abstract: The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 11, 2015
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Kunio Saruta, Norimitsu Hayashi, Osamu Sakurai, Hiroaki Sawamoto, Eri Ooboki